丹参酮ⅡA磺酸钠对冠心病心肌缺血患者TC、TG、LDL-C水平的影响

Sodium tanshinone Ⅱ A sulfonic acid in patients with coronary heart disease, myocardial ischemia of TC, TG,LDL-C level

目的探讨分析丹参酮ⅡA磺酸钠对冠心病心肌缺血患者临床效果,尤其是对患者TC、TG、LDL-C水平的影响及改善情况。方法回顾分析本院2013年10月~2016年4月收治的心肌缺血150例,根据患者接受治疗方法的不同,将其分为两组。其中,对照组73例冠心病心肌缺血患者,口服拜阿司匹林肠溶片、单硝酸异山梨酯来配合治疗;观察组则在上述常规方法的基础上,联合丹参酮ⅡA磺酸钠来实施治疗。记录对比分析两组患者的临床实效性。结果观察组与对照组相比,临床疗效更加显著,差异有统计学意义(P<0.05)。对照组73例患者,治疗前后血脂水平无明显变化;观察组77例患者,治疗前后TC、TG、LDL-C水平变化显著(P<0.05);此外,观察组与对照组相比,TC、TG、LDL-C水平改善情况更佳,差异有统计学意义(P<0.05)。结论丹参酮ⅡA磺酸钠用于治疗冠心病心肌缺血患者,可起到预防动脉硬化、调节血管衰老因子的水平。

Objective To ecplore the clinical effects of hematoblastic activation function for the patients with coronary heart disease unstable angina blood stasis by Sulfotanshinone Sodium Injection.Methods150patients were divided into two groups,the control group of73patients with conventional treatment,the observation group of77patients on the basis of conventional methods,combined with sodium tanshinoneⅡA to treat,the clinical effectiveness of patients.Results The total effective rate of experiment group were higher than control group(P<0.05).Compared with the control group,the improvement of TC,TG and LDL-C levels in the observation group was better,the difference is statistically significant(P<0.05).Conclusion It can improve the hematobastic activation function for the patients with coronary heart disease unstable angina blood stasis by Sulfotanshinone Sodium Injection,it can improve the clinical symptons.It can also prevent atherosclerosis and regulate the level of vascular aging factor.